Livermore

TRV GP IV, LLC

SEC CIK
0001688325

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 7, 2026.SEC

Positions
2
0 vs. Q1 2026
Total value
$253.68M
−$13.22M (−5.0%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

TRV GP IV, LLC holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
MAZEMAZE THERAPEUTICS INCCOM4,473,958$133.5M52.63%00.0%UnchangedView
TNGXTANGO THERAPEUTICS INCCOM6,374,574$120.18M47.37%00.0%UnchangedView

13F filings by quarter

TRV GP IV, LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 7, 20262$253.68Mvs. Q1 2026SEC
Q1 2026May 7, 20262$266.9Mvs. Q4 2025SEC
Q4 2025Feb 13, 20262$255.12Mvs. Q3 2025SEC
Q3 2025Nov 13, 20252$273.96Mvs. Q2 2025SEC
Q2 2025Aug 8, 20253$163.32Mvs. Q1 2025SEC
Q1 2025May 9, 20253$92.85Mvs. Q4 2024SEC
Q4 2024Feb 13, 20252$80.18Mvs. Q3 2024SEC
Q3 2024Nov 6, 20243$162.09Mvs. Q2 2024SEC
Q2 2024Aug 9, 20243$202.2Mvs. Q1 2024SEC
Q1 2024May 13, 20243$206.36Mvs. Q4 2023SEC
Q4 2023Feb 14, 20243$246.15Mvs. Q3 2023SEC
Q3 2023Nov 13, 20233$265.43Mvs. Q2 2023SEC
Q2 2023Aug 10, 20233$110.67Mvs. Q1 2023SEC
Q1 2023May 12, 20233$139.9Mvs. Q4 2022SEC
Q4 2022Feb 14, 20235$235.17Mvs. Q3 2022SEC
Q3 2022Nov 3, 20225$171.14Mvs. Q2 2022SEC
Q2 2022Aug 12, 20225$152.07Mvs. Q1 2022SEC
Q1 2022May 10, 20225$272.97Mvs. Q4 2021SEC
Q4 2021Feb 14, 20225$347.76Mvs. Q3 2021SEC
Q3 2021Nov 5, 20215$440.74Mvs. Q2 2021SEC
Q2 2021Aug 11, 20214$210.05Mvs. Q1 2021SEC
Q1 2021May 12, 20214$271.45M–SEC